Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,703 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
Hatano E, Okuno M, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S. Hatano E, et al. Among authors: doi k. J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):634-45. doi: 10.1002/jhbp.254. Epub 2015 Apr 29. J Hepatobiliary Pancreat Sci. 2015. PMID: 25926024 Clinical Trial.
Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.
Nagayama S, Hasegawa S, Hida K, Kawada K, Hatano E, Nakamura K, Seo S, Taura K, Yasuchika K, Matsuo T, Zaima M, Kanazawa A, Terajima H, Tada M, Adachi Y, Nishitai R, Manaka D, Yoshimura T, Doi K, Horimatsu T, Mitsuyoshi A, Yoshimura K, Niimi M, Matsumoto S, Sakai Y, Uemoto S. Nagayama S, et al. Among authors: doi k. Int J Clin Oncol. 2017 Apr;22(2):316-323. doi: 10.1007/s10147-016-1050-5. Epub 2016 Oct 17. Int J Clin Oncol. 2017. PMID: 27752787 Clinical Trial.
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Okuno M, Hatano E, Toda R, Nishino H, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokuka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S. Okuno M, et al. Among authors: doi k. J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):496-509. doi: 10.1002/jhbp.747. Epub 2020 Jun 9. J Hepatobiliary Pancreat Sci. 2020. PMID: 32362018 Free article. Clinical Trial.
Edaravone reduces ischemia-reperfusion injury mediators in rat liver.
Taniguchi M, Uchinami M, Doi K, Yoshida M, Sasaki H, Tamagawa K, Horiuchi T, Tanaka K. Taniguchi M, et al. Among authors: doi k. J Surg Res. 2007 Jan;137(1):69-74. doi: 10.1016/j.jss.2006.06.033. Epub 2006 Oct 24. J Surg Res. 2007. PMID: 17064733
Granulocyte and Monocyte Adsorption Therapy in Patients With Sepsis: A Feasibility Study.
Nishida O, Nakamura T, Nakada T, Takahashi G, Masuda Y, Tsubouchi H, Kakihana Y, Sakamoto Y, Takasu O, Suzuki H, Nakazawa K, Kobayashi I, Doi K, Uchiyama S, Kitamura N, Kotani T, Kuriyama N, Hattori N, Suzuki Y, Tatsumi H, Moriyama K. Nishida O, et al. Among authors: doi k. Artif Organs. 2025 Jan 17. doi: 10.1111/aor.14943. Online ahead of print. Artif Organs. 2025. PMID: 39825588
2,703 results